+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Clinical Chemistry Analyzers - Global Market Trajectory & Analytics

  • ID: 338893
  • Report
  • February 2022
  • Region: Global
  • 581 Pages
  • Global Industry Analysts, Inc

Global Clinical Chemistry Analyzers Market to Reach US$15.7 Billion by the Year 2026


Clinical chemistry analyzers are widely used for analyzing bodily fluids like blood serum, urine and plasma using technologies like photometric or colorimetric testing, latex agglutination and ion-selective potentiometry. Growth in the global market is set to be driven by rapid expansion of the diagnostics domain, increasing geriatric population and rising cases of chronic medical conditions. Clinical chemistry analyzers are widely used to assess kidney or liver function, metabolic state and various diseases. Ongoing technological advances have resulted in better products intended to simplify workflow, push turnaround times and deliver accurate results. The market growth is also aided by rising sample volumes that require high-capacity analyzing solutions. The increase in spending by private research agencies is expected to further propel the market growth.

Amid the COVID-19 crisis, the global market for Clinical Chemistry Analyzers estimated at US$12.1 Billion in the year 2020, is projected to reach a revised size of US$15.7 Billion by 2026, growing at a CAGR of 4.5% over the analysis period. Reagents, one of the segments analyzed in the report, is projected to grow at a 4.9% CAGR to reach US$10.6 Billion by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Analyzers segment is readjusted to a revised 4.1% CAGR for the next 7-year period. This segment currently accounts for a 25% share of the global Clinical Chemistry Analyzers market. The high uptake of reagents is attributed to their cost-effective nature, optimal sensitivity, superior precision and linearity that ensure desirable performance. These advantages are prompting a large number of clinicians to rely on reagents for precise and accurate diagnosis.



The U.S. Market is Estimated at $4.4 Billion in 2021, While China is Forecast to Reach $1.6 Billion by 2026


The Clinical Chemistry Analyzers market in the U.S. is estimated at US$4.4 Billion in the year 2021. The country currently accounts for a 34.17% share in the global market. China, the world`s second largest economy, is forecast to reach an estimated market size of US$1.6 Billion in the year 2026 trailing a CAGR of 6% through the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.7% and 4.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.1% CAGR while Rest of European market (as defined in the study) will reach US$1.7 Billion by the end of the analysis period. North America enjoys a dominant position due to rising aging population, increasing cases of lifestyle and chronic medical conditions. The regional market is gaining from rising healthcare expenditure, presence of well-established healthcare infrastructure, high penetration of sophisticated instruments and supportive initiatives by governments. High growth is expected in the Asia-Pacific region as a result of outsourcing of clinical chemistry analyzer production to countries like China and India. China and India is witnessing an increase in medical tourism, which is expected to stimulate the clinical chemistry analyzers market.

Basic Metabolic Panel (Test) Segment to Reach $5.5 Billion by 2026


The basic metabolic panel test panels are widely used to test and analyze indicators related to various diseases through routine or disease-specific tests. The segment is bound to gain from increasing prevalence of chronic medical conditions coupled with the preventive healthcare trend. In the global Basic Metabolic Panel (Test) segment, USA, Canada, Japan, China and Europe will drive the 4.8% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$3.3 Billion in the year 2020 will reach a projected size of US$4.6 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$582.5 Million by the year 2026, while Latin America will expand at a 5.7% CAGR through the analysis period.

Select Competitors (Total 98 Featured) -

  • Abbott Laboratories
  • Beckman Coulter Inc.
  • Biobase Biodusty (Shandong), Co., Ltd.
  • Dirui Industrial Co., Ltd.
  • EKF Diagnostics
  • ELITechGroup
  • Erba Mannheim
  • F. Hoffmann-La Roche Ltd.
  • Genrui Biotech Inc.
  • Hitachi High-Tech Corporation
  • Horiba, Ltd.
  • KPM Analytics, Inc.
  • Medica Corporation
  • Ortho Clinical Diagnostics
  • Randox Laboratories Ltd.
  • SFRI SAS
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Shenzhen New Industries Biomedical Engineering Co., Ltd.
  • Siemens Healthineers AG
  • Teco Diagnostics
  • Thermo Fisher Scientific Inc.
  • Trivitron Medical Systems (P) Ltd.
Frequently Asked Questions about the Global Market for Clinical Chemistry Analyzers

What is the estimated value of the Global Market for Clinical Chemistry Analyzers?

The Global Market for Clinical Chemistry Analyzers was estimated to be valued at $12.1 Billion in 2020.

What is the growth rate of the Global Market for Clinical Chemistry Analyzers?

The growth rate of the Global Market for Clinical Chemistry Analyzers is 4.4%, with an estimated value of $15.7 Billion by 2026.

What is the forecasted size of the Global Market for Clinical Chemistry Analyzers?

The Global Market for Clinical Chemistry Analyzers is estimated to be worth $15.7 Billion by 2026.

Who are the key companies in the Global Market for Clinical Chemistry Analyzers?

Key companies in the Global Market for Clinical Chemistry Analyzers include Abbott Laboratories, Beckman Coulter Inc., Biobase Biodusty (Shandong), Co., Ltd., Dirui Industrial Co., Ltd., EKF Diagnostics, ELITechGroup, Erba Mannheim, F. Hoffmann and Genrui Biotech Inc..

Table of Contents

I. METHODOLOGY


II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Clinical Chemistry Analyzers - Global Key Competitors Percentage Market Share in 2022 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • A Prelude to Clinical Chemistry Analyzers
  • Impact of COVID-19 and the Looming Recession
  • 2020 Marked as a Year of Disruption & Transformation
  • As the Race between the Virus & Vaccines Intensifies, Where is the World Economy Headed in 2021
  • World Economic Growth Projections (Real GDP, Annual % Change) for 2020 through 2022
  • Impact of COVID-19 on Clinical Chemistry Analyzers Market
  • Clinical Chemistry Analyzers Market Attains Equilibrium following COVID-19 Acid Test
  • Global Market Prospects and Outlook
  • Global Clinical Chemistry Analyzers Market to Remain in Dynamic & Effervescent State
  • Reagents & Metabolic Panel Test: Key Segments Catalyzing Growth of Clinical Chemistry Analyzers Market
  • North America Displays Strongest Bonding with Clinical Chemistry Analyzers Market
  • Market Outlook
  • Competition
  • New Developments
  • Market Challenges
  • Recent Market Activity

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

  • Rising Aging Population Propels the Market for Clinical Chemistry Analyzers
  • Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
  • Elderly Population (65+ Years) as a % of Total Population by Developed, Less Developed and Least Developed Regions: 2019 & 2030
  • Shrinking Form Factor of Core Laboratories
  • Rising Incidence of Chronic Diseases Propels the Need for Clinical Chemistry Analyzers
  • Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
  • World Diabetes and Population Statistics (2019, 2030 & 2045)
  • Global Annual Medical Cost of CVD in US$ Billion: 2010, 2015, 2020, 2025 and 2030
  • Dry Chemistry Analyzers Register Steady Growth
  • Portable Albumin Analyzers Gain Popularity
  • Improvements in Clinical Laboratories Design to Drive Operational Efficiencies
  • Continuous Flow Analysis Registers Significant Growth
  • Growing Automation Propels Market Growth
  • Rising Emphasis on Lab Automation to Augur Well for Market Growth
  • World Laboratory Automation Market in US$ Billion for Years 2018, 2020, 2022, 2024 & 2026
  • Supplementing Labs and Automated Instrumentation
  • Picking a Chemical Analyzer
  • Increasing Healthcare Expenditure Drives the Demand for market
  • World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023
  • Clinical Chemistry Keeps Buzzing & Boasts Ample Room for Product Innovations
  • Influx of New Assays & Biomarkers Propels Market Growth
  • Focus on New Connections and Data
  • Focus on Research and Development
  • Greater Number of Tests for HIV and Sexually Transmitted Diseases Amplify Growth
  • Global HIV Prevalence: Number of People Living with AIDs (in Thousands) by Region for 2018
  • Number of AIDS-Related Deaths (in Thousands) by Region for 2018

4. GLOBAL MARKET PERSPECTIVE


III. MARKET ANALYSIS

UNITED STATES

  • Clinical Chemistry Analyzers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E)

CANADA

JAPAN

  • Clinical Chemistry Analyzers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E)

CHINA

  • Clinical Chemistry Analyzers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E)

EUROPE

  • Clinical Chemistry Analyzers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E)

FRANCE

  • Clinical Chemistry Analyzers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E)

GERMANY

  • Clinical Chemistry Analyzers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E)

ITALY

UNITED KINGDOM

  • Clinical Chemistry Analyzers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E)

SPAIN


RUSSIA


REST OF EUROPE

ASIA-PACIFIC

  • Clinical Chemistry Analyzers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E)

AUSTRALIA

  • Clinical Chemistry Analyzers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2022 (E)

INDIA

  • Clinical Chemistry Analyzers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2022 (E)

SOUTH KOREA


REST OF ASIA-PACIFIC

LATIN AMERICA

  • Clinical Chemistry Analyzers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2022 (E)

ARGENTINA


BRAZIL


MEXICO


REST OF LATIN AMERICA

MIDDLE EAST

  • Clinical Chemistry Analyzers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2022 (E)

IRAN


ISRAEL


SAUDI ARABIA


UNITED ARAB EMIRATES


REST OF MIDDLE EAST

AFRICA

  • Clinical Chemistry Analyzers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2022 (E)

IV. COMPETITION

  • Total Companies Profiled: 98

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Abbott Laboratories
  • Beckman Coulter Inc.
  • Biobase Biodusty (Shandong), Co., Ltd.
  • Dirui Industrial Co., Ltd.
  • EKF Diagnostics
  • ELITechGroup
  • Erba Mannheim
  • F. Hoffmann-La Roche Ltd.
  • Genrui Biotech Inc.
  • Hitachi High-Tech Corporation
  • Horiba, Ltd.
  • KPM Analytics, Inc.
  • Medica Corporation
  • Ortho Clinical Diagnostics
  • Randox Laboratories Ltd.
  • SFRI SAS
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Shenzhen New Industries Biomedical Engineering Co., Ltd.
  • Siemens Healthineers AG
  • Teco Diagnostics
  • Thermo Fisher Scientific Inc.
  • Trivitron Medical Systems (P) Ltd.